Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-113342

Options or other derivatives

  • Chief Medical Officer acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Berkowitz Noah · Chief Medical Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-09-30 Grant or award : show line 1 in the form Stock Options (Right to Buy) +135,000 135,000 D
2026-09-30 Grant or award : show line 2 in the form Restricted Stock Units +180,000 180,000 D
2026-09-30 Grant or award : show line 3 in the form Performance Stock Units +135,000 135,000 D
Loading xslF345X06/tm2626734-2_4seq1.xml…